Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1785 | QURE uniQure N.V. - Ordinary Shares | 43.35 USD | +4.68% | -7.41% | +58.62% | +198.97% | 2.73 B USD | ||
| 1786 | TRVI Trevi Therapeutics, Inc. - Common Stock | 18.27 USD | -6.31% | +1.61% | +33.85% | +206.03% | 2.59 B USD | ||
| 1790 | IMNM Immunome, Inc. - Common Stock | 24.04 USD | -1.44% | +12.71% | +27.13% | +177.92% | 2.72 B USD | ||
| 1795 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 10.65 USD | -3.09% | +10.02% | +25.00% | +19.39% | 2.71 B USD | ||
| 1830 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 42.90 USD | -2.52% | +13.25% | +55.10% | -1.13% | 2.55 B USD | ||
| 1842 | NKTR Nektar Therapeutics - Common Stock | 71.91 USD | -3.99% | +7.91% | +26.16% | -1.86% | 2.43 B USD | ||
| 1845 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.51 USD | -3.65% | -4.04% | +45.48% | +109.72% | 2.43 B USD | ||
| 1849 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 29.68 USD | -2.56% | +8.12% | +29.66% | -26.48% | 2.45 B USD | ||
| 1873 | VCEL Vericel Corporation - Common Stock | 46.46 USD | -1.04% | +3.50% | +26.70% | +27.81% | 2.37 B USD | ||
| 1874 | KOD Kodiak Sciences Inc - Common Stock | 38.42 USD | +0.31% | +1.35% | +27.68% | +867.76% | 2.40 B USD | ||
| 1878 | NTLA Intellia Therapeutics, Inc. - Common Stock | 16.41 USD | -5.85% | -6.39% | +19.17% | +19.61% | 2.29 B USD | ||
| 1882 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.72 USD | -5.78% | -3.71% | +59.00% | +505.71% | 2.37 B USD | ||
| 1889 | BHVN Biohaven Ltd. Common Shares | 15.48 USD | -0.39% | +4.03% | +38.21% | -8.62% | 2.33 B USD | ||
| 1911 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.98 USD | -3.39% | +1.63% | +20.53% | -13.22% | 2.19 B USD | ||
| 1914 | PHVS Pharvaris N.V. - Ordinary Shares | 34.23 USD | -1.04% | +0.94% | +8.15% | +90.48% | 2.23 B USD | ||
| 1922 | ZLAB Zai Lab Limited - American Depositary Shares | 18.97 USD | -1.96% | -2.87% | +15.11% | -28.92% | 2.13 B USD | ||
| 1927 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 37.57 USD | -1.80% | +3.44% | +14.68% | +21.59% | 2.18 B USD | ||
| 1932 | ABCL AbCellera Biologics Inc. - Common Shares | 7.15 USD | -7.02% | -3.25% | +27.91% | +80.10% | 2.18 B USD | ||
| 1945 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 24.11 USD | +3.74% | +14.59% | +39.36% | +173.05% | 2.14 B USD | ||
| 1949 | ADMA ADMA Biologics Inc - Common Stock | 9.20 USD | -0.11% | +5.63% | +13.72% | -49.31% | 2.13 B USD |
Haberler Biotechnology Stocks
BofA, tahkim kararı sonrası Beam hisse görüşünü korudu
Beam Therapeutics hisseleri neden düşüyor?
Prime Medicine hisseleri neden bugün yükseliyor?
Incyte hissesi 118,77 dolarda 52 haftalık zirve yaptı
Prime Medicine hisseleri Beam ile kazanılan tahkimden sonra yükseldi
Edgewise Therapeutics hissesi 43,96 dolarla rekor kırdı
Stifel, Vertex satın alımı sonrası Crinetics hissesini tut’a düşürdü
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |